These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14726470)

  • 21. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
    Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
    Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma.
    Yu J; Bulk E; Ji P; Hascher A; Koschmieder S; Berdel WE; Müller-Tidow C
    Int J Oncol; 2009 Jul; 35(1):175-9. PubMed ID: 19513565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of ephrins and Eph receptors in cancer.
    Surawska H; Ma PC; Salgia R
    Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eph-ephrin bidirectional signaling in physiology and disease.
    Pasquale EB
    Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
    Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
    Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
    Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
    J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel putative tyrosine kinase receptor encoded by the eph gene.
    Hirai H; Maru Y; Hagiwara K; Nishida J; Takaku F
    Science; 1987 Dec; 238(4834):1717-20. PubMed ID: 2825356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics.
    London M; Gallo E
    Mol Biol Rep; 2020 Jul; 47(7):5523-5533. PubMed ID: 32621117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity.
    Darling TK; Lamb TJ
    Front Immunol; 2019; 10():1473. PubMed ID: 31333644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.
    Zhou D; Ren K; Wang J; Ren H; Yang W; Wang W; Li Q; Liu X; Tang F
    Oncol Lett; 2018 Apr; 15(4):5257-5263. PubMed ID: 29552165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of p54
    Yamamoto R; Osawa T; Sasaki Y; Yamamoto S; Anai M; Izumi K; Matsumura Y; Sakai J; Aburatani H; Mizokami A; Kodama T; Tanaka T
    Oncotarget; 2018 Feb; 9(12):10510-10524. PubMed ID: 29535823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EphA5 and EphA6: regulation of neuronal and spine morphology.
    Das G; Yu Q; Hui R; Reuhl K; Gale NW; Zhou R
    Cell Biosci; 2016; 6():48. PubMed ID: 27489614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review.
    Frederiks CN; Lam SW; Guchelaar HJ; Boven E
    Cancer Treat Rev; 2015 Dec; 41(10):935-50. PubMed ID: 26585358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.
    Li S; Ma Y; Xie C; Wu Z; Kang Z; Fang Z; Su B; Guan M
    Oncotarget; 2015 Sep; 6(26):22587-97. PubMed ID: 26041887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.
    DuSablon A; Kent S; Coburn A; Virag J
    Cardiovasc Diabetol; 2014 Aug; 13():114. PubMed ID: 25166508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy.
    O'Neal WT; Griffin WF; Kent SD; Faiz F; Hodges J; Vuncannon J; Virag JA
    Front Physiol; 2014; 5():132. PubMed ID: 24795639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.
    Cell; 1997 Aug; 90(3):403-4. PubMed ID: 9267020
    [No Abstract]   [Full Text] [Related]  

  • 38. Physical and functional interactome atlas of human receptor tyrosine kinases.
    Salokas K; Liu X; Öhman T; Chowdhury I; Gawriyski L; Keskitalo S; Varjosalo M
    EMBO Rep; 2022 Jun; 23(6):e54041. PubMed ID: 35384245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.
    Aregger M; Lawson KA; Billmann M; Costanzo M; Tong AHY; Chan K; Rahman M; Brown KR; Ross C; Usaj M; Nedyalkova L; Sizova O; Habsid A; Pawling J; Lin ZY; Abdouni H; Wong CJ; Weiss A; Mero P; Dennis JW; Gingras AC; Myers CL; Andrews BJ; Boone C; Moffat J
    Nat Metab; 2020 Jun; 2(6):499-513. PubMed ID: 32694731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genome-wide study reveals copy number variants exclusive to childhood obesity cases.
    Glessner JT; Bradfield JP; Wang K; Takahashi N; Zhang H; Sleiman PM; Mentch FD; Kim CE; Hou C; Thomas KA; Garris ML; Deliard S; Frackelton EC; Otieno FG; Zhao J; Chiavacci RM; Li M; Buxbaum JD; Berkowitz RI; Hakonarson H; Grant SF
    Am J Hum Genet; 2010 Nov; 87(5):661-6. PubMed ID: 20950786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.